Stay updated on Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a backend/platform update behind the page. No study content or status information is affected.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Record History now shows the latest version as Revision: v3.5.3, replacing the previous Revision: v3.5.2.SummaryDifference0.1%

- Check22 days agoChange DetectedUpdated the study’s overall status to **Completed** and revised its **Recruitment Status**. The prior **Active, not recruiting** state was removed.SummaryDifference0.4%

- Check29 days agoChange DetectedRevision: v3.5.2 has been added, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedThe history now includes Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.